Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 8 de 8
Filtre
1.
Tuberculosis and Respiratory Diseases ; : 257-266, 2016.
Article Dans Anglais | WPRIM | ID: wpr-125743

Résumé

BACKGROUND: Idiopathic pulmonary fibrosis is a common interstitial lung disease; it is a chronic, progressive, and fatal lung disease of unknown etiology. Over the last two decades, knowledge about the underlying mechanisms of pulmonary fibrosis has improved markedly and facilitated the identification of potential targets for novel therapies. However, despite the large number of antifibrotic drugs being described in experimental pre-clinical studies, the translation of these findings into clinical practices has not been accomplished yet. NADH:quinone oxidoreductase 1 (NQO1) is a homodimeric enzyme that catalyzes the oxidation of NADH to NAD+ by various quinones and thereby elevates the intracellular NAD⁺ levels. In this study, we examined the effect of increase in cellular NAD⁺ levels on bleomycin-induced lung fibrosis in mice. METHODS: C57BL/6 mice were treated with intratracheal instillation of bleomycin. The mice were orally administered with β-lapachone from 3 days before exposure to bleomycin to 1-3 weeks after exposure to bleomycin. Bronchoalveolar lavage fluid (BALF) was collected for analyzing the infiltration of immune cells. In vitro, A549 cells were treated with transforming growth factor β1 (TGF-β1) and β-lapachone to analyze the extracellular matrix (ECM) and epithelial-mesenchymal transition (EMT). RESULTS: β-Lapachone strongly attenuated bleomycin-induced lung inflammation and fibrosis, characterized by histological staining, infiltrated immune cells in BALF, inflammatory cytokines, fibrotic score, and TGF-β1, α-smooth muscle actin accumulation. In addition, β-lapachone showed a protective role in TGF-β1–induced ECM expression and EMT in A549 cells. CONCLUSION: Our results suggest that β-lapachone can protect against bleomycin-induced lung inflammation and fibrosis in mice and TGF-β1–induced EMT in vitro, by elevating the NAD+/NADH ratio through NQO1 activation.


Sujets)
Animaux , Souris , Actines , Bléomycine , Liquide de lavage bronchoalvéolaire , Cytokines , Transition épithélio-mésenchymateuse , Matrice extracellulaire , Fibrose , Fibrose pulmonaire idiopathique , Techniques in vitro , Inflammation , Maladies pulmonaires , Pneumopathies interstitielles , Poumon , NAD , Pneumopathie infectieuse , Fibrose pulmonaire , Quinones , Facteur de croissance transformant bêta-1 , Facteurs de croissance transformants
2.
Experimental & Molecular Medicine ; : e142-2015.
Article Dans Anglais | WPRIM | ID: wpr-42471

Résumé

Bucillamine is used for the treatment of rheumatoid arthritis. This study investigated the protective effects of bucillamine against cisplatin-induced damage in auditory cells, the organ of Corti from postnatal rats (P2) and adult Balb/C mice. Cisplatin increases the catalytic activity of caspase-3 and caspase-8 proteases and the production of free radicals, which were significantly suppressed by pretreatment with bucillamine. Bucillamine induces the intranuclear translocation of Nrf2 and thereby increases the expression of gamma-glutamylcysteine synthetase (gamma-GCS) and glutathione synthetase (GSS), which further induces intracellular antioxidant glutathione (GSH), heme oxygenase 1 (HO-1) and superoxide dismutase 2 (SOD2). However, knockdown studies of HO-1 and SOD2 suggest that the protective effect of bucillamine against cisplatin is independent of the enzymatic activity of HO-1 and SOD. Furthermore, pretreatment with bucillamine protects sensory hair cells on organ of Corti explants from cisplatin-induced cytotoxicity concomitantly with inhibition of caspase-3 activation. The auditory-brainstem-evoked response of cisplatin-injected mice shows marked increases in hearing threshold shifts, which was markedly suppressed by pretreatment with bucillamine in vivo. Taken together, bucillamine protects sensory hair cells from cisplatin through a scavenging effect on itself, as well as the induction of intracellular GSH.


Sujets)
Animaux , Mâle , Souris , Rats , Antioxydants/métabolisme , Apoptose/effets des médicaments et des substances chimiques , Caspase-3/métabolisme , Caspase 8/métabolisme , Lignée cellulaire , Cisplatine/toxicité , Cystéine/analogues et dérivés , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Techniques de knock-down de gènes , Glutathion/métabolisme , Heme oxygenase-1/génétique , Espace intracellulaire/métabolisme , Détoxication de phase II/génétique , Facteur-2 apparenté à NF-E2/génétique , Monoxyde d'azote/biosynthèse , Organe spiral/effets des médicaments et des substances chimiques , Interférence par ARN , Espèces réactives de l'oxygène/métabolisme , Superoxide dismutase/génétique
3.
Electrolytes & Blood Pressure ; : 55-65, 2014.
Article Dans Anglais | WPRIM | ID: wpr-183770

Résumé

Cisplatin is one of the most widely used and highly effective drug for the treatment of various solid tumors; however, it has dose-dependent side effects on the kidney, cochlear, and nerves. Nephrotoxicity is the most well-known and clinically important toxicity. Numerous studies have demonstrated that several mechanisms, including oxidative stress, DNA damage, and inflammatory responses, are closely associated with cisplatin-induced nephrotoxicity. Even though the establishment of cisplatin-induced nephrotoxicity can be alleviated by diuretics and pre-hydration of patients, the prevalence of cisplatin nephrotoxicity is still high, occurring in approximately one-third of patients who have undergone cisplatin therapy. Therefore it is imperative to develop treatments that will ameliorate cisplatin-nephrotoxicity. In this review, we discuss the mechanisms of cisplatin-induced renal toxicity and the new strategies for protecting the kidneys from the toxic effects without lowering the tumoricidal activity.


Sujets)
Humains , Cisplatine , Diurétiques , Altération de l'ADN , Traitement médicamenteux , Rein , Stress oxydatif , Prévalence
4.
Experimental & Molecular Medicine ; : e12-2013.
Article Dans Anglais | WPRIM | ID: wpr-165476

Résumé

Hair cells at the base of the cochlea appear to be more susceptible to damage by the aminoglycoside gentamicin than those at the apex. However, the mechanism of base-to-apex gradient ototoxicity by gentamicin remains to be elucidated. We report here that gentamicin caused rodent cochlear hair cell damages in a time- and dose-dependent manner. Hair cells at the basal turn were more vulnerable to gentamicin than those at the apical turn. Gentamicin-conjugated Texas Red (GTTR) uptake was predominant in basal turn hair cells in neonatal rats. Transient receptor potential vanilloid 1 (TRPV1) and 4 (TRPV4) expression was confirmed in the cuticular plate, stereocilia and hair cell body of inner hair cells and outer hair cells. The involvement of TRPV1 and TRPV4 in gentamicin trafficking of hair cells was confirmed by exogenous calcium treatment and TRPV inhibitors, including gadolinium and ruthenium red, which resulted in markedly inhibited GTTR uptake and gentamicin-induced hair cell damage in rodent and zebrafish ototoxic model systems. These results indicate that the cytotoxic vulnerability of cochlear hair cells in the basal turn to gentamicin may depend on effective uptake of the drug, which was, in part, mediated by the TRPV1 and TRPV4 proteins.


Sujets)
Animaux , Rats , Mort cellulaire/effets des médicaments et des substances chimiques , Polarité de la cellule/effets des médicaments et des substances chimiques , Survie cellulaire/effets des médicaments et des substances chimiques , Relation dose-effet des médicaments , Gadolinium/métabolisme , Gentamicine/métabolisme , Cellules ciliées auditives/effets des médicaments et des substances chimiques , Cellules ciliées auditives internes/effets des médicaments et des substances chimiques , Rat Sprague-Dawley , Rouge de ruthénium/métabolisme , Canaux cationiques TRPV/métabolisme , Facteurs temps , Xanthènes/métabolisme , Danio zébré
5.
Experimental & Molecular Medicine ; : 393-400, 2006.
Article Dans Anglais | WPRIM | ID: wpr-53151

Résumé

Recently, it has been reported that curcumin, which is known as a potent antioxidant, acts as a non-stressful and non-cytotoxic inducer of the cytoprotective heme oxygenase (HO)-1. In this study, naturally occurring curcuminoids, such as pure curcumin, demethoxycurcumin (DMC) and bis-demethoxycurcumin (BDMC), were compared for their potential ability to modulate HO-1 expression and cytoprotective activity in human endothelial cells. All three curcuminoids could induce HO-1 expression and HO activity with differential levels. The rank order of HO activity was curcumin, DMC and BDMC. In comparison with endothelial protection against H2O2-induced cellular injury, cytoprotective capacity was found to be highest with curcumin, followed by DMC and BDMC. Interestingly, cytoprotective effects afforded by curcuminoids were considerably associated with their abilities to enhance HO activity. Considering that the main difference among the three curcuminoids is the number of methoxy groups (none for BDMC, one for DMC, and two for curcumin), the presence of methoxy groups in the ortho position on the aromatic ring was suggested to be essential to enhance HO-1 expression and cytoprotection in human endothelial cells. Our results may be useful in designing more efficacious HO-1 inducers which could be considered as promising pharmacological agents in the development of therapeutic approaches for the prevention or treatment of endothelial diseases caused by oxidative damages.


Sujets)
Humains , Transduction du signal , Modèles biologiques , Peroxyde d'hydrogène/effets indésirables , Heme oxygenase-1/métabolisme , Cellules endothéliales/effets des médicaments et des substances chimiques , Altération de l'ADN/effets des médicaments et des substances chimiques , Cytoprotection/effets des médicaments et des substances chimiques , Curcumine/analogues et dérivés
6.
Immune Network ; : 182-187, 2003.
Article Dans Anglais | WPRIM | ID: wpr-116896

Résumé

BACKGROUND: The mushroom Phellinus linteus (PL) has been shown to have the anti-tumor and immunostimulatory effects. We hypothesized that the hot water extract of PL (WEPL) exerts its significant immunostimulatory effect by inducing production of the Th1-derived cytokine interferon-gamma (IFN-gamma) by T lymphocytes. METHODS: T lymphocytes were isolated from the mice fed with 200 mg/kg of WEPL once a day for 4 weeks, and then stimulated with the mitogen concanavaline A (Con A). IFN-gamma gene and intracellular protein expressions were analyzed by RT-PCR and flow cytometry, respectively. The production of IFN-gamma was measured by enzyme-linked immunosorbent assay. RESULTS: WEPL significantly enhanced the transcription of IFN-gamma mRNA. The effect of WEPL on IFN-gamma expression was further supported by a concomitant increase in the number of cells with intracellular IFN-gamma protein as well as the secretion of IFN-gamma. However, WEPL did not modulate either gene expression or protein secretion of interleukin-4, a Th2-associated cytokine, by Con A-stimulated T lymphocytes. CONCLUSION: Our results demonstrate that one of the potentially beneficial anti-tumor and immunostimulatory effects of WEPL may be mediated through the enhancement of IFN-gamma secretion by T lymphocytes.


Sujets)
Animaux , Souris , Administration par voie orale , Agaricales , Cytokines , Test ELISA , Cytométrie en flux , Expression des gènes , Interféron gamma , Interleukine-4 , ARN messager , Protéine A staphylococcique , Lymphocytes T , Eau
SÉLECTION CITATIONS
Détails de la recherche